Trials / Unknown
UnknownNCT02704741
Clinical Study of the CO2RE Laser Device Performance for Vaginal Atrophy Treatments
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 61 (actual)
- Sponsor
- Syneron Medical · Industry
- Sex
- Female
- Age
- 35 Years
- Healthy volunteers
- Accepted
Summary
The CO2RE laser system is a fractional CO2 laser that is FDA approved under a 510(k) K101321 for dermatologic procedures requiring ablation and coagulation of soft tissues, including the skin Eligible subjects will undergo 3 treatments in 4±1 weeks interval on the Vagina (External/Vulva and Internal/Vagina) with the CO2RE device according to study protocol. Subject will return for to 5 follow-up (FU) visits: 1 week ± 2 days post first treatment visit and 1, 3, 6 and 12 months after last (third) treatment (± 2 weeks). Methodology described in protocol to evaluate efficacy of treatments will be carried out at each visit at the clinic.
Detailed description
This study is a Prospective clinical study to demonstrate the CO2RE laser device for safety and efficacy for Vaginal Atrophy. Up to a total of 60 healthy candidates, seeking vaginal treatment from the participating investigator will be enrolled at a participating study site. Subjects will receive three (3) CO2RE treatments. Each subject will be followed for additional 5 post treatment visits (FU visits) that will be conducted at: * One week post first treatment - 1wk FU ± 2 days (Safety). * 1 month post last treatment - 1m FU ± 2 weeks (efficacy \& Safety). * 3 months post last treatment - 3m FU ± 2 weeks (efficacy \& Safety). * 6 months post last treatment - 6m FU ± 2 weeks (efficacy \& Safety). * 12 months post last treatment - 12m FU ± 2 weeks (efficacy \& Safety).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CO2RE | The CO2RE system device is intended for dermatological procedures requiring ablation, coagulation and resurfacing of soft tissue, including skin |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2019-06-01
- Completion
- 2019-09-01
- First posted
- 2016-03-10
- Last updated
- 2018-06-14
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02704741. Inclusion in this directory is not an endorsement.